Search Results - "Bernabe, Luis Feo"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Multimodal treatment approach in a case of feline ventral abdominal angiosarcoma by Maldonado-Moreno, Alba, Blanchart, Marta, Clemente-Vicario, Pachi, Gonzalez-Gash, Esteban, Feo-Bernabe, Luis

    Published in Veterinary record case reports (01-02-2019)
    “…A 14-year-old male neutered domestic shorthair cat presented for a recurrent angiosarcoma. Previously, the mass was incompletely resected twice at the…”
    Get full text
    Journal Article
  3. 3

    A retrospective review of cats with suspected false positive results in point-of-care feline leukemia virus tests and concurrent immune-mediated anemia by Robert, Laura Izquierdo, Puig, Jordi, Tumbarello, Michele, Farigola, Montserrat, Seth, Mayank, Mesa, Ignacio, Bernabe, Luis Feo

    “…To describe clinical findings, diagnosis, treatment, and survival in 18 cats with anemia of suspected immune-mediated origin (ASIMO) and conflicting results…”
    Get full text
    Journal Article
  4. 4

    Successful Treatment of 3 Dogs With Fluoroquinolone-Resistant Escherichia coli Associated Granulomatous Colitis by Merino-Gutierrez, Virginia, Puig, Jordi, Feo-Bernabe, Luis

    Published in Topics in companion animal medicine (01-03-2022)
    “…Successful resolution of Escherichia coli associated granulomatous colitis (ECGC) is becoming a challenge due to the development of fluoroquinolone resistant E…”
    Get full text
    Journal Article
  5. 5

    Feline leishmaniosis: diagnosis, treatment and outcome in 16 cats by Fernandez-Gallego, Ana, Feo Bernabe, Luis, Dalmau, Anabel, Esteban-Saltiveri, Diego, Font, Artur, Leiva, Marta, Ortuñez-Navarro, Amparo, Peña, Maria-Teresa, Tabar, Maria-Dolores, Real-Sampietro, Llibertat, Saló, Ferran, Lloret, Albert, Bardagí, Mar

    Published in Journal of feline medicine and surgery (01-10-2020)
    “…Objectives Leishmaniosis is a vector-borne disease and in European countries is caused by Leishmania infantum. Cats are considered secondary reservoirs of the…”
    Get full text
    Journal Article
  6. 6

    Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose by Bernabe, Luis Feo, Portela, Roberta, Nguyen, Sandra, Kisseberth, William C, Pennell, Michael, Yancey, Mark F, London, Cheryl A

    Published in BMC veterinary research (30-09-2013)
    “…BACKGROUND: The receptor kinase inhibitor toceranib phosphate (Palladia) was approved for use in dogs in 2009 using a dose of 3.25 mg/kg administered every…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11